Improve Patient Engagement & Gather Insights
Helping pharmaceutical manufacturers by providing compliant patient owned and controlled Real World Data.
Collect Real World Data
Vaultt allows for the real-time collection of Patient Reported Outcomes related to any number of outcomes or Quality of Life measures, directly from patients in their real world environment. Instruments can be customized and data collected periodically and automatically without the need for phone calls, paper forms or in-person visits.
Vaultt engages patient feedback and Real World Data reports to help you communicate outcomes with payers and governments. Vaultt helps to accumulate payer-relevant evidence in order to proactively address the efficacy-to-evidence gap for market access decisions, and develop a strong value proposition for novel or established treatments.
Care Plan Adherence
Vaultt’s powerful platform supports patients and their families in managing the most complex chronic conditions. Our secure and comprehensive information management and storage platform helps to improve patient adherence. Studies show that patients who have direct access to their health records and treatment plans are more likely to adhere to those treatment plans.
Reduce Burden on Patients & CRO Staff
Paper-based methods to share and collect data are inefficient and are a burden to both patients and Contract Research Organization Staff. Vaultt’s digitized solution streamlines the process.
Share insights with Health Care Professionals
Engage your Health Care Professional audience with patient specific insights gleaned from the collected data, continually honing your messaging.
Secure by Design
It’s more than accessible data, it’s about security & privacy.
Vaultt web and mobile apps are secure by design with true end-to-end encryption to protect users’ sensitive personal data.
Data encryption & decryption occur on the user’s side and the server side meaning only the user and invited members can access the data.
At Boehringer Ingelheim Canada, we believe innovative technologies can offer better healthcare for Idiopathic Pulmonary Fibrosis/Progressive Fibrosing–Interstitial Lung Disease patients. These patients are at an increased risk of an emergency due to COVID-19 from pre-existing respiratory symptoms. Enabling patients and their caregivers’ quick access to personal and up to date health information is important to ensure the best health outcome.